[go: up one dir, main page]

EP2190870A4 - Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations - Google Patents

Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations

Info

Publication number
EP2190870A4
EP2190870A4 EP08828507A EP08828507A EP2190870A4 EP 2190870 A4 EP2190870 A4 EP 2190870A4 EP 08828507 A EP08828507 A EP 08828507A EP 08828507 A EP08828507 A EP 08828507A EP 2190870 A4 EP2190870 A4 EP 2190870A4
Authority
EP
European Patent Office
Prior art keywords
cell
melanocyte
lineage
marker
cell marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08828507A
Other languages
German (de)
English (en)
Other versions
EP2190870A1 (fr
Inventor
Peter Roderick Dunbar
Oliver Horlacher
Vaughan John Feisst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auckland Uniservices Ltd
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of EP2190870A1 publication Critical patent/EP2190870A1/fr
Publication of EP2190870A4 publication Critical patent/EP2190870A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP08828507A 2007-08-28 2008-08-28 Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations Withdrawn EP2190870A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ56097707 2007-08-28
PCT/NZ2008/000223 WO2009028968A1 (fr) 2007-08-28 2008-08-28 Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations

Publications (2)

Publication Number Publication Date
EP2190870A1 EP2190870A1 (fr) 2010-06-02
EP2190870A4 true EP2190870A4 (fr) 2010-12-01

Family

ID=40387522

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08828507A Withdrawn EP2190870A4 (fr) 2007-08-28 2008-08-28 Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations

Country Status (3)

Country Link
EP (1) EP2190870A4 (fr)
AU (1) AU2008293138A1 (fr)
WO (1) WO2009028968A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010098682A1 (fr) * 2009-02-27 2010-09-02 Auckland Uniservices Limited Marqueur cellulaire d'une lignée de mélanocytes et de cellules cancéreuses et ses utilisations

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000874A2 (fr) * 1999-06-30 2001-01-04 Ludwig Institute For Cancer Research Antigenes associes au cancer et leurs utilisations
WO2001079556A2 (fr) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Nouveaux genes, compositions et methodes destines a l'identification, l'evaluation, la prevention, et la therapie de cancers humains
WO2002064626A2 (fr) * 2000-10-27 2002-08-22 Pe Corporation (Ny) Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees
WO2004093804A2 (fr) * 2003-04-18 2004-11-04 Five Prime Therapeutics, Inc. Polypeptides humains codes par des polynucleotides et methodes d'utilisation associees

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254846A (fr) * 1982-11-30 1989-05-30 Anthony Albino Anticorps monoclonaux contre les melanocytes et les melanomes
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
DE10238298A1 (de) * 2002-08-21 2004-03-04 Beiersdorf Ag Verwendung von Antisense-Oligonucleotiden zur Behandlung von degenerativen Hauterscheinungen
EP1530636B1 (fr) * 2002-08-21 2010-08-18 The University Of British Columbia Traitement des melanomes au moyen de la reduction des taux de clusterine
AU2005300688B2 (en) * 2004-11-03 2012-02-02 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000874A2 (fr) * 1999-06-30 2001-01-04 Ludwig Institute For Cancer Research Antigenes associes au cancer et leurs utilisations
WO2001079556A2 (fr) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Nouveaux genes, compositions et methodes destines a l'identification, l'evaluation, la prevention, et la therapie de cancers humains
WO2002064626A2 (fr) * 2000-10-27 2002-08-22 Pe Corporation (Ny) Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees
WO2004093804A2 (fr) * 2003-04-18 2004-11-04 Five Prime Therapeutics, Inc. Polypeptides humains codes par des polynucleotides et methodes d'utilisation associees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009028968A1 *

Also Published As

Publication number Publication date
EP2190870A1 (fr) 2010-06-02
WO2009028968A8 (fr) 2009-05-22
AU2008293138A1 (en) 2009-03-05
WO2009028968A1 (fr) 2009-03-05

Similar Documents

Publication Publication Date Title
IL267138A (en) Improved composition of cells and methods for its preparation
ZA201000436B (en) Novel esterases and their use
ZA200908904B (en) Multipotent/pluripotent cells and methods
IL205977A0 (en) 5-anilinoimidazopyridines and methods of use
IL199836A (en) Human stem cells are isolated and used
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
PT2163169E (pt) Sistemas e métodos para a personalização de carteiras de mão
GB0719577D0 (en) Microimplant devices and methods of making and use thereof
EP2173822A4 (fr) Formulations d'encre et procédés de fabrication de formulations d'encre
IL206125A0 (en) Azaindolizines and methods of use
EP2227540A4 (fr) Dédifférenciation de cellules humaines
EP2069477A4 (fr) Repulsion chimique de cellules
GB0717376D0 (en) Composition and manufacture thereof
GB2448589B (en) High Altitude structures and related methods
EP2170988A4 (fr) Compositions de polystyrène et procédés de préparation et d'utilisation correspondantes
ZA201004894B (en) Nuctraceutical composition and methods of use
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
EP2190870A4 (fr) Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations
GB0914782D0 (en) Perfluoroparacyclophane and methods of synthesis and use thereof
ZA201004893B (en) Nuctraceutical composition and methods of use
EP2185685A4 (fr) Nouveaux procédés et nouvelles lignées cellulaires
PL383088A1 (pl) Sposób i układ do otrzymywania wodoru
GB0716515D0 (en) Regionalised endoderm cells and uses thereof
GB0809852D0 (en) Regionalised endoderm cells and uses thereof
AU2007905437A0 (en) Markers of Endothelial Cells and Uses Thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100324

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20101029

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: FEISST, VAUGHAN, JOHN

Inventor name: HORLACHER, OLIVER

Inventor name: DUNBAR, PETER, RODERICK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20110520